Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 8Genitourinary 7Breast 6Dermatologic 5Thoracic 4Other hematologic neoplasm 2Head & Neck 2Plasma cell 1Other neoplasm 1Other 1Myeloid 1Lymphoid 1Gynecologic 1

Conditions

Myelodysplastic Syndromes 1477Leukemia, Myeloid, Acute 1238Leukemia, Myelogenous, Chronic, BCR-ABL Positive 863Leukemia 745Precursor Cell Lymphoblastic Leukemia-Lymphoma 703Myeloproliferative Disorders 629Leukemia, Myelomonocytic, Chronic 455Lymphoma, Non-Hodgkin 447Primary Myelofibrosis 430Multiple Myeloma 423Leukemia, Lymphocytic, Chronic, B-Cell 408Hodgkin Disease 384Lymphoma 343Leukemia, Myeloid, Chronic-Phase 335Blast Crisis 282Polycythemia Vera 267Leukemia, Myeloid, Accelerated Phase 263Lymphoma, Follicular 254Lymphoma, Mantle-Cell 253Burkitt Lymphoma 246Lymphoma, Large B-Cell, Diffuse 244Lymphoma, B-Cell, Marginal Zone 225Congenital Abnormalities 215Lymphoma, Large-Cell, Immunoblastic 201Myelodysplastic-Myeloproliferative Diseases 199Thrombocythemia, Essential 196Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 196Anemia, Refractory, with Excess of Blasts 194Hematologic Neoplasms 193Neoplasms, Plasma Cell 184

Interventions

decitabine and cedazuridine drug combination 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Patient Preference × Myeloid × Clear all
NCT05883956 2025-03-20

PREFER-HMA

Otsuka Australia Pharmaceutical Pty Ltd

Phase 3 Active not recruiting
13 enrolled
MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Patient Preference

Data powered by HemOnc (CC BY 4.0) Colophon âš¡